BridgeBio Pharma grants 57,853 restricted stock units to 32 new employees
BridgeBio Pharma approved restricted stock units covering 57,853 common shares for 32 new employees on October 14, 2026. Each award will vest 25% on November 16, 2027, followed by quarterly vesting of one-twelfth of the remaining shares. Vesting is subject to continued employment with the company or one of its subsidia